2 recruiting, 1 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 2, Completed 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Curative Surgery: new trials by email Literature Review of Curative Surgery trials Research Report on Curative Surgery
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ctDNA-Guided Immunotherapy for dMMR/MSI-H Colon Cancer PD-1 inhibitor, CTLA-4 inhibitor, ctDNA/MRD testing - Colon Cancer, Deficient Mismatch Repair | Phase 2 | Recruiting | Fudan University | 23 | 2026-09-14 | 2026-09-25 |
| CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative Chemotherapy Versus Immediate Resection in patIents With resecTable BiliarY Tract Cancers (BTC) at High Risk for Recurrence Gemcitabine, Nab paclitaxel, Cisplatin - Biliary Tract Cancer, Cholangiocarcinoma | Phase 2 / Phase 3 | Recruiting | Gruppo Oncologico del Nord-Ovest | 300 | 2023-11-07 | 2026-09-09 |
| CA209-891: Neoadjuvant and Adjuvant Nivolumab as Immune Checkpoint Inhibition in Oral Cavity Cancer Nivolumab, Surgery, Radiotherapy, Nivolumab, Surgery, Chemoradiotherapy - Squamous Cell Carcinoma of the Oral Cavity | Phase 2 | Completed | The Clatterbridge Cancer Centre NHS Foundation Trust | 21 | 2019-05-10 | 2025-02-25 |
Biliary Tract Neoplasms (1) · Carcinoma, Squamous Cell (1) · Cholangiocarcinoma (1) · Colonic Neoplasms (1) · Head and Neck Neoplasms (1) · Neoplasm, Residual (1) · Squamous Cell Carcinoma of Head and Neck (1)
Fudan University (1) · Gruppo Oncologico del Nord-Ovest (1) · The Clatterbridge Cancer Centre NHS Foundation Trust (1)
China (1) · Italy (1) · United Kingdom (1)
Joseph Sacco, MBChB (1) · Monica Niger, MD (1)
PMID 30914290, PMID 30998813, PMID 37368098, PMID 38589856
2017 (1)